Allopurinol
Who holds supplier records for Allopurinol? 22 organisations hold a current record for Allopurinol: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 20 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (13), China (2), Netherlands (1), Taiwan (1) and 3 other countries (3); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Allopurinol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/allopurinol
Reading the evidence
- 22 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
13 of the 20 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (22)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Allopurinol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsCEPActive DMF 2506, 2870 · latest filing Feb 1977
- ANHUI POLY PHARM CO LTDChinaCEPActive DMF 40108 · latest filing Jul 2024
- Exemed PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 36113 · latest filing Jul 2021
- HALEOS LABS LTDIndiaCEPActive DMF 36130 · latest filing Nov 2022
- HARMAN FINOCHEM LTDIndiaCEP Company GMP cert on recordActive DMF 17128 · latest filing Jan 2004
- HENAN DONGTAI PHARM CO LTDChinaCEPActive DMF 39797 · latest filing Apr 2024
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 35422 · latest filing Dec 2020
- INDOCO REMEDIES LTDIndiaCEP Company GMP cert on recordActive DMF 21239 · latest filing Jan 2008
- Iol Chemicals And Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 37104 · latest filing Jan 2023
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 21676 · latest filing Jul 2008
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 16409 · latest filing Apr 2003
- SCI PHARMTECH INCTaiwanCEPActive DMF 24876 · latest filing Apr 2011
- SIGNA SA DE CVCEPActive DMF 15841 · latest filing Feb 2002
- SUPRIYA LIFESCIENCE LTDIndiaCEPActive DMF 39568 · latest filing Mar 2024
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 32429 · latest filing Jan 2018
- UNION QUIMICO FARMACEUTICA SAActive DMF 16472 · latest filing Mar 2003
- IndiaCEP Company GMP cert on record
- Egis Pharmaceuticals PLCHungaryCEP Company GMP cert on recordInactive DMF 4084 · latest filing Feb 1981
- MexicoCEP
- IndiaCEP
- SpainCEP
- ASSURGEN PHARMA PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (20)
Certificates of Suitability on the EDQM register for Allopurinol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ANHUI POLY PHARM. CO., LTD. Anqing | CN | CEP 2024-410 - Rev 00 Allopurinol | Sept 2026 | — |
| HARMAN FINOCHEM LIMITED Mumbai | IN | CEP 2001-433 - Rev 07 Allopurinol | Jul 2026 | — |
| EXEMED PHARMACEUTICALS Vadodara | IN | CEP 2021-331 - Rev 02 Allopurinol | Jun 2026 | Inspected Feb 2025 Hungary |
| SUPRIYA LIFESCIENCE LIMITED Mumbai | IN | CEP 2024-127 - Rev 00 Allopurinol | Jun 2026 | — |
| ASSURGEN PHARMA PRIVATE LIMITED Visakhapatnam | IN | CEP 2022-390 - Rev 01 Allopurinol | Apr 2026 | Inspected May 2023 Hungary, outside 3-year window |
| HALEOS LABS LIMITED Hyderabad | IN | CEP 2021-239 - Rev 02 Allopurinol | Feb 2026 | — |
| ANUH PHARMA LTD. Mumbai | IN | CEP 2023-078 - Rev 01 Allopurinol | Jan 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2025-441 - Rev 00 Allopurinol, Site-II | Nov 2025 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2000-015 - Rev 08 Allopurinol | Oct 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 1998-118 - Rev 08 Allopurinol | Jul 2025 | — |
| HENAN DONGTAI PHARM CO., LTD. Anyang | CN | CEP 2023-232 - Rev 00 Allopurinol | Jun 2025 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2008-211 - Rev 05 Allopurinol | Jun 2025 | — |
| INDOCO REMEDIES LIMITED Mumbai | IN | CEP 2008-017 - Rev 05 Allopurinol | Mar 2025 | — |
| SIGNA S.A. DE C.V. Toluca | MX | CEP 2001-335 - Rev 04 Allopurinol | Jul 2024 | — |
| IOL CHEMICALS AND PHARMACEUTICALS LTD Ludhiana | IN | CEP 2023-029 - Rev 00 Allopurinol | Jun 2024 | — |
| EGIS Pharmaceuticals PLC Budapest | HU | CEP 2014-364 - Rev 01 Allopurinol, Synthetic route B | Nov 2023 | Inspected Nov 2025 Hungary |
| SINBIOTIK S.A. DE C.V. Tlalnepantla de Baz | MX | R0-CEP 2022-070 - Rev 00 Allopurinol | Jul 2023 | — |
| STYRAX PHARMA PRIVATE LIMITED Anakapalli | IN | R0-CEP 2022-119 - Rev 00 Allopurinol | Jun 2023 | — |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | R1-CEP 2003-004 - Rev 02 Allopurinol | Dec 2017 | — |
| SCI Pharmtech, Inc. Taoyuan | TW | R1-CEP 2002-164 - Rev 00 Allopurinol | Jan 2009 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Allopurinol are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- PKU HEALTHCARE CORP LTDInactive DMF 23954 · filed Jul 2010
- AXITEC CO LTDInactive DMF 17855 · filed Oct 2004
- LABORATORIO CHIMICO INTERNAZIONALE SPAInactive DMF 15945 · filed Apr 2002
- RHONE-POULENC SANTE INCInactive DMF 6452 · filed Jul 1986
- FABBRICA ITALIANA SINTETICI SPAInactive DMF 6373 · filed May 1986
- ORGAMOL SAInactive DMF 5235 · filed Jan 1984
- DIOSYNTH BVInactive DMF 4950 · filed Feb 1983
- SIEGFRIED AGInactive DMF 3480 · filed Mar 1979
- DINAMITE DIPHARMA SPAInactive DMF 2534 · filed Oct 1975
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Allopurinol is a xanthine oxidase inhibitor that is primarily used to decrease uric acid levels in the blood. It is commonly prescribed to prevent gout flares and to manage tumor lysis syndrome during chemotherapy.
Chemical identity
- IUPAC name
- 1,5-dihydropyrazolo[5,4-d]pyrimidin-4-one
- Canonical SMILES
- C1=NNC2=C1C(=O)NC=N2
- InChIKey
- OFCNXPDARWKPPY-UHFFFAOYSA-N
- Synonyms
- Zyloprim API, allopurinolum, bw 56-158, bw-56-158, duzallo component allopurinol, lopurin, nsc-101655, nsc-1390, suspendol, takanarumin, zyloprim
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Xanthine Oxidase Inhibitor
- Mechanism of action
- Xanthine Oxidase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Allopurinol?
22 organisations hold an active US FDA Type II Drug Master File or a CEP for Allopurinol: TAPI NL BV (Netherlands), ANHUI POLY PHARM CO LTD (China), Exemed Pharmaceuticals (India), HALEOS LABS LTD (India), HARMAN FINOCHEM LTD (India), HENAN DONGTAI PHARM CO LTD (China), Hetero Drugs Limited (India) and INDOCO REMEDIES LTD (India), and 14 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Allopurinol Drug Master Files are active?
TAPI NL BV (DMF 2506, 2870), ANHUI POLY PHARM CO LTD (DMF 40108), Exemed Pharmaceuticals (DMF 36113), HALEOS LABS LTD (DMF 36130), HARMAN FINOCHEM LTD (DMF 17128), HENAN DONGTAI PHARM CO LTD (DMF 39797), Hetero Drugs Limited (DMF 35422) and INDOCO REMEDIES LTD (DMF 21239) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Allopurinol records mean?
9 organisations have only inactive Type II DMFs for Allopurinol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Allopurinol have a European Certificate of Suitability?
Yes. 20 organisations hold a valid CEP for Allopurinol on the EDQM register, including ANHUI POLY PHARM. CO., LTD. Anqing (CN), HARMAN FINOCHEM LIMITED Mumbai (IN), EXEMED PHARMACEUTICALS Vadodara (IN), SUPRIYA LIFESCIENCE LIMITED Mumbai (IN), ASSURGEN PHARMA PRIVATE LIMITED Visakhapatnam (IN) and HALEOS LABS LIMITED Hyderabad (IN) and 14 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Allopurinol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Allopurinol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.